AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. IBM
3. PRIM
4. MU
5. DPZ
6. NAVN
7. DFTX
8. META
9. IMNN
10. ACN

Go back to AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635
(NASDAQ: ABCL) Delayed: 5.73 -0.01 (0.17%)
Previous Close $5.74    52 Week High $ 
Open $5.73    52 Week Low $ 
Day High $5.73    P/E N/A 
Day Low $5.73    EPS $ 
Volume 225,642